Ranking Year:
Top 5 New Entrants companies in Carbonic anhydrase inhibitor
by Most Patent Filing In 1 Year in the world in 2019
The Carbonic anhydrase inhibitor top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 1 Year Carbonic anhydrase inhibitor New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti-glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, idiopathic intracranial hypertension, neurological disorders, or osteoporosis.
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Michigan, United States | Patent: 5 | ||
2 | Indiana, United States | Patent: 2 | ||
3 | China | Patent: 1 | ||
4 | South Korea | Patent: 1 | ||
5 | Beijing Shi, China | Patent: 1 |
Page generation time:
Apr 29 2025